Celecoxib Macleods Pharma Uk

Celecoxib Macleods Pharma UK is a prescription‑only oral medication that contains the active ingredient celecoxib, a selective COX‑2 inhibitor classified as a non‑steroidal anti‑inflammatory drug (NSAID). It is marketed in the European Union and supplied in tablet form, though specific strength information is not disclosed. The product is intended for use under medical supervision for conditions involving pain, inflammation, and swelling, and related chronic musculoskeletal disorders.

Celecoxib Macleods Pharma UK is prescribed for several inflammatory and painful musculoskeletal conditions where reduction of pain and swelling is desired.

- Osteoarthritis – relief of joint pain and stiffness. - Rheumatoid arthritis – management of chronic inflammatory joint disease. - Ankylosing spondylitis – alleviation of spinal pain and reduced inflammation. - Acute pain – short‑term treatment of moderate to severe pain, such as postoperative or dental pain. - Familial adenomatous polyposis – reduction of colorectal polyp burden (off‑label in some regions).

The safety profile of celecoxib includes both frequently reported and less common adverse events.

Common: - Headache - Diarrhea - Nausea - Abdominal pain - Elevated blood pressure

Serious: - Cardiovascular thrombotic events (e.g., heart attack, stroke) - Gastrointestinal ulceration or bleeding - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Liver enzyme elevations indicating hepatic injury

Clinicians should evaluate patient history and risk factors before initiating celecoxib therapy.

- Known hypersensitivity to celecoxib or other NSAIDs. - History of cardiovascular disease, including hypertension or heart failure. - Prior gastrointestinal ulceration, bleeding, or perforation. - Severe hepatic or renal impairment. - Pregnancy, especially the third trimester, unless benefits outweigh risks. - Concomitant use of anticoagulants or antiplatelet agents.

Celecoxib may interact with several medicines, affecting efficacy or safety.

Avoid: - Anticoagulants (e.g., warfarin) – increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors – additive gastrointestinal toxicity. - Certain antihypertensives (e.g., ACE inhibitors, diuretics) – reduced blood‑pressure control. - Lithium – increased serum lithium levels. - Methotrexate – higher risk of toxicity.

Use with caution: - Selective serotonin reuptake inhibitors (SSRIs) – potential for bleeding. - Corticosteroids – heightened gastrointestinal risk. - Cyclosporine – possible renal function impact.